Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06385795 · ClinicalTrials.gov registry record · Phase 2
A Study of NOE-115 in Women With Vasomotor Symptoms Due to Menopause
A Phase 2 study, sponsored by Noema Pharma.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT06385795 is a Phase 2 study that has completed, run by Noema Pharma. The registered enrollment target is 40 participants.
The verdict
NCT06385795, a Phase 2 study, has completed, sponsored by Noema Pharma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety, tolerability, and preliminary effectiveness of NOE-115 on moderate to severe vasomotor symptoms (hot flashes) due to menopause in women.
Interventions
- DRUG NOE-115
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-04-22 |
| Est. Completion | 2025-08-13 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06385795
The ClinicalTrials.gov registry entry for NCT06385795 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Noema Pharma, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NOE-115 is the first listed.
NCT06385795 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06385795 about?
NCT06385795 is a clinical study titled "A Study of NOE-115 in Women With Vasomotor Symptoms Due to Menopause". The purpose of this study is to determine the safety, tolerability, and preliminary effectiveness of NOE-115 on moderate to severe vasomotor symptoms (hot flashes) due to menopause in women.
What is the current status of trial NCT06385795?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2024-04-22. Estimated completion is 2025-08-13.
What interventions are being tested in trial NCT06385795?
The interventions under investigation include: NOE-115 (DRUG).
Who is sponsoring clinical trial NCT06385795?
This trial is sponsored by Noema Pharma, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.